The FDA may allow broader access to testosterone therapy for men with low libido without known medical cause. Manufacturers ...
INDIANAPOLIS (WISH) — This week, the Food and Drug Administration approved Addyi, the first medication for low libido in women younger than 65 years of age. Low libido affects 1 in 8 postmenopausal ...
FDA is encouraging supplemental NDAs for TRT to treat low libido in idiopathic hypogonadism, reflecting preliminary ...
Share on Pinterest The FDA has expanded its approval of a libido-boosting drug to postmenopausal women. Xvision/Getty Images On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results